A
$ Value
$0
Shares
103,000
Price
$0
Filed
Feb 4
Insider
Name
Bredt David
Title
Chief Scientific Officer
CIK
0002022087
Roles
Officer
Transaction Details
Transaction Date
2026-02-02
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
103,000
Footnotes
The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date.
Filing Info
Bredt David's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-19 | RAPP | M | $11K |
| 2026-02-19 | RAPP | M | $0 |
| 2026-02-17 | RAPP | ▼ | $25K |
| 2026-02-17 | RAPP | ▼ | $156K |
| 2026-02-17 | RAPP | ▼ | $65K |
| 2026-02-02 | RAPP | A | $0 |
| 2026-01-15 | RAPP | ▼ | $223K |
| 2026-01-15 | RAPP | ▼ | $5K |
| 2025-12-31 | RAPP | A | — |
| 2025-12-31 | RAPP | ▼ | $197K |
Other Insiders at RAPP (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Ignelzi Troy A.
Chief Financial Officer
|
— | — | 2026-02-02 |
|
Ceesay Abraham
Chief Executive Officer
|
— | $320K | 2026-02-18 |
| Third Rock Ventures V, L.P. | — | $17.2M | 2026-04-17 |
|
Sevigny Jeffrey
Chief Medical Officer
|
— | — | 2026-02-02 |
|
Gault Cheryl
Chief Operating Officer
|
— | $282K | 2026-03-30 |
|
Bredt David
Chief Scientific Officer
|
— | $247K | 2026-02-19 |
|
Yeleswaram Krishnaswamy
Chief Development Officer
|
— | $1.8M | 2026-04-17 |